Breadcrumb

CIM News

Two studies confirm efficiency of saliva tests for COVID-19

Testing is the cornerstone of the fight against COVID-19, and a test that can be self-administered would greatly increase the options for case...

Could an antidepressant slow COVID-19 progression?

RI-MUHC researchers launch a clinical trial of fluvoxamine, a drug that has already proven efficient in reducing lung injury in animal studies and...

Clinical Innovation Platform at the RI-MUHC announces first member company

Health tech accelerator welcomes AltPAP Innovation to its new state-of-the-art facility

The RI-MUHC leads new clinical trial of COVID-19 treatment for hospitalized patients

Phase 2 study tests LAU-7b, a Canadian drug with dual antiviral and inflammation-controlling effects

Dr. Ron Gottesman is Quebec’s Royal College Mentor of the Year

Mentorship applies to the whole team, whole person

New services for cancer patients at the RI-MUHC Centre for Innovative Medicine

The Centre for Innovative Medicine and Cedars Cancer Centre jointly offer additional space for infusion treatments

Project led by RI-MUHC researchers wins award at Oncopole's Priorité patient Competition

New grant supports integration of peer support and counselling ...

Understanding the psychological trauma related to facial transplantation

Dr. Mirko Gilardino is co-author of study that examines issues around patients’ consent

Supporting those grieving requires “literacy,” researcher Mary Ellen Macdonald suggests

Grief amidst the pandemic is an increasing reality in communities worldwide

Protecting lung cancer patients from COVID-19 – and learning from the experience

A study led by Dr. Nathaniel Bourganim tracked changes in treatment plans

Explore news and events at the RI-MUHC